Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 2476 AL 2490

PUBMED

Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.

Egevad G, Petkova VY, Vilholm OJ.

J Parkinsons Dis. 2014;4(3):321-6. doi: 10.3233/JPD-140379.

0

0

0

PUBMED

Discrimination and categorization of emotional facial expressions and faces in Parkinson's disease.

Alonso-Recio L, Martín P, Rubio S, Serrano JM.

J Neuropsychol. 2014 Sep;8(2):269-88. doi: 10.1111/jnp.12029.

0

0

0

PUBMED

Changing panoramas and new horizons in Parkinson's disease.

Samuel M, Ashkan K.

Br J Hosp Med (Lond). 2014 Feb;75(2):66-7. No abstract available.

0

0

0

PUBMED

Reduced thalamic volume in Parkinson disease with REM sleep behavior disorder: volumetric study.

Salsone M, Cerasa A, Arabia G, Morelli M, Gambardella A, Mumoli L, Nisticò R, Vescio B, Quattrone A.

Parkinsonism Relat Disord. 2014 Sep;20(9):1004-8. doi: 10.1016/j.parkreldis.2014.06.012.

0

0

0

PUBMED

Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study.

Mizuno Y, Nomoto M, Hasegawa K, Hattori N, Kondo T, Murata M, Takeuchi M, Takahashi M, Tomida T; Rotigotine Trial Group..

Parkinsonism Relat Disord. 2014 Dec;20(12):1388-93. doi: 10.1016/j.parkreldis.2014.10.005.

0

0

0

PUBMED

Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.

Kotagal V, Albin RL, Müller ML, Koeppe RA, Studenski S, Frey KA, Bohnen NI.

J Gerontol A Biol Sci Med Sci. 2014 Dec;69(12):1569-75. doi: 10.1093/gerona/glu070.

0

0

0

PUBMED

Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease.

Martínez-Martín P, Hernández B, Ricart J; FAST Study Group..

Neurologia. 2014 Apr;29(3):153-60. doi: 10.1016/j.nrl.2012.12.008. English, Spanish.

0

0

0

PUBMED

A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson's disease.

Troeung L, Egan SJ, Gasson N.

BMC Psychiatry. 2014 Jan 27;14:19. doi: 10.1186/1471-244X-14-19.

0

0

0

PUBMED

Identification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for Parkinson's disease.

Fujimaki T, Saiki S, Tashiro E, Yamada D, Kitagawa M, Hattori N, Imoto M.

PLoS One. 2014 Jun 24;9(6):e100395. doi: 10.1371/journal.pone.0100395.

0

0

0

PUBMED

Functional imaging in pre-motor Parkinson's disease.

Arnaldi D, Morbelli S, Picco A, Ferrara M, Buschiazzo A, Famà F, De Carli F, Nobili F.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):366-75. Review.

0

0

0

PUBMED

COMT gene and risk for Parkinson's disease: a systematic review and meta-analysis.

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JA.

Pharmacogenet Genomics. 2014 Jul;24(7):331-9. doi: 10.1097/FPC.0000000000000056. Review.

0

0

0

PUBMED

Hypothesis: somatic mosaicism and Parkinson disease.

Kim HJ, Jeon BS.

Exp Neurobiol. 2014 Dec;23(4):271-6. doi: 10.5607/en.2014.23.4.271. Review.

0

0

0

PUBMED

A computational model of altered gait patterns in parkinson's disease patients negotiating narrow doorways.

Muralidharan V, Balasubramani PP, Chakravarthy VS, Lewis SJ, Moustafa AA.

Front Comput Neurosci. 2014 Jan 9;7:190. doi: 10.3389/fncom.2013.00190.

0

0

0

PUBMED

Visual short-term memory deficits associated with GBA mutation and Parkinson's disease.

Zokaei N, McNeill A, Proukakis C, Beavan M, Jarman P, Korlipara P, Hughes D, Mehta A, Hu MT, Schapira AH, Husain M.

Brain. 2014 Aug;137(Pt 8):2303-11. doi: 10.1093/brain/awu143.

0

0

0

PUBMED

Managing depression in Parkinson's patients: risk factors and clinical pearls.

Biemiller R, Richard IH.

Neurodegener Dis Manag. 2014;4(4):329-36. doi: 10.2217/nmt.14.31. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy